Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States
Hepatitis C virus (HCV) disproportionately affects rural communities, where health services are geographically dispersed. It remains unknown whether proximity to a syringe services program (SSP) is associated ... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 28, 2024 Category: Drugs & Pharmacology Authors: Eric Romo, Thomas J. Stopka, Bill M. Jesdale, Bo Wang, Kathleen M. Mazor and Peter D. Friedmann Tags: Research Source Type: research
The role of stigma in cannabis use disclosure: an exploratory study
Although cannabis use incidence, societal acceptance, and legislation all trend positively, cannabis remains federally illegal in the USA. Prior studies have revealed that patients are reluctant to disclose th... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 26, 2024 Category: Drugs & Pharmacology Authors: Daniel D. King, Christopher J. Gill, Carey S. Cadieux and Neha Singh Tags: Research Source Type: research
Safe inhalation pipe provision (SIPP): protocol for a mixed-method evaluation of an intervention to improve health outcomes and service engagement among people who use crack cocaine in England
Over 180,000 people use crack cocaine in England, yet provision of smoking equipment to support safer crack use is prohibited under UK law. Pipes used for crack cocaine smoking are often homemade and/or in sho... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 23, 2024 Category: Drugs & Pharmacology Authors: Magdalena Harris, Jenny Scott, Vivian Hope, Joanna Busza, Sedona Sweeney, Andrew Preston, Mat Southwell, Niamh Eastwood, Cedomir Vuckovic, Caitlynne McGaff, Ian Yoon, Louise Wilkins, Shoba Ram, Catherine Lord, Philippe Bonnet, Peter Furlong & hellip; Tags: Research Source Type: research
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose
Opioid-related mortality is a rising public health concern in France, where opioids were in 2021 implicated in 75% of overdose deaths. Opioid substitution treatment (OST) was implicated in almost half of death... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 23, 2024 Category: Drugs & Pharmacology Authors: Aur élie Aquizerate, Morgane Rousselet, Axel Cochard, Marylène Guerlais, Marie Gerardin, Emilie Lefebvre, Mélanie Duval, Edouard-Jules Laforgue and Caroline Victorri-Vigneau Tags: Research Source Type: research
Reported xylazine exposure highly associated with overdose outcomes in a rapid community assessment among people who inject drugs in Baltimore
Addressing xylazine harms are now a critical harm reduction priority, but relatively little epidemiological information exists to determine prevalence, magnitude, and correlates of xylazine use or related outc... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 22, 2024 Category: Drugs & Pharmacology Authors: Danielle German, Becky Genberg, Olivia Sugarman, Brendon Saloner, Anne Sawyer, Jennifer L. Glick, Molly Gribbin and Colin Flynn Tags: Brief Report Source Type: research
Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site
Early in the COVID-19 pandemic, there was an urgent need to establish isolation spaces for people experiencing homelessness who were exposed to or had COVID-19. In response, community agencies and the City of ... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 20, 2024 Category: Drugs & Pharmacology Authors: Gillian Kolla, Chowdhury Nishwara Tarannum, Kaitlin Fajber, Fiqir Worku, Kris Norris, Cathy Long, Raphaela Fagundes, Anne Rucchetto, Eileen Hannan, Richard Kikot, Michelle Klaiman, Michelle Firestone, Ahmed Bayoumi, Gab Laurence and Kate Hayman Tags: Research Source Type: research
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years
Consistent reports from health professionals suggest that heroin is commonly used by patients undergoing opioid maintenance treatment (OMT) in France, potentially jeopardizing their recovery process. However, ... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 19, 2024 Category: Drugs & Pharmacology Authors: Eric Janssen, Mike Vuolo, Stanislas Spilka and Guillaume Airagnes Tags: Research Source Type: research
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder
The rise in injection drug use in the USA has led to an increase in injection site infections. We performed a national survey of people who use drugs to evaluate common drug use preparation, harm reduction pra... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 19, 2024 Category: Drugs & Pharmacology Authors: Laura R. Marks, Michael J. Durkin, Kelly Ayres and Matthew Ellis Tags: Research Source Type: research
Testing the test strips: laboratory performance of fentanyl test strips
The overdose crisis driven by synthetic opioids continues to escalate in the USA. We evaluated the efficacy of multiple manufacturing lots of a fentanyl test strip (FTS) to detect fentanyl and fentanyl analogs... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 18, 2024 Category: Drugs & Pharmacology Authors: John C. Halifax, Lilly Lim, Daniel Ciccarone and Kara L. Lynch Tags: Research Source Type: research
The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis
Over the past decade in the USA, increases in overdose rates of cocaine and psychostimulants with opioids were highest among Black, compared to White, populations. Whether fentanyl has contributed to the rise ... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 17, 2024 Category: Drugs & Pharmacology Authors: Angela T. Estadt, Brian N. White, JaNelle M. Ricks, Kathryn E. Lancaster, Staci Hepler, William C. Miller and David Kline Tags: Research Source Type: research
First German-speaking harm reduction conference in Vienna
The first Harm Reduction DACH Conference [DACH = D (Germany), A (Austria), CH (Switzerland)] took place in Vienna on June 23rd, 2023, and focused on tobacco harm reduction. It is the first conference bringing ... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 16, 2024 Category: Drugs & Pharmacology Authors: Larissa Steimle, Simon Flei ßner, Hans Haltmayer, Thilo Beck, Alfred Springer and Heino Stöver Tags: Meeting Report Source Type: research
Correction: Health workers ’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia
(Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 13, 2024 Category: Drugs & Pharmacology Authors: Elena Cama, Mitch Beadman, Kim Beadman, Max Hopwood and Carla Treloar Tags: Correction Source Type: research
A call to create integrated services to better address the needs of migrants who use drugs in Europe
Each year, thousands of migrants enter the EU. Data on drug use in migrant populations are scarce and inconclusive. However, several risk factors make them particularly vulnerable to engaging in problematic dr... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 13, 2024 Category: Drugs & Pharmacology Authors: Lena van Selm, Trenton M. White, Camila A. Picchio, Ana Requena-M éndez, Machteld Busz, Roberto Perez Gayo, Aline Pouille, Pedro Mateu Gelabert and Jeffrey V. Lazarus Tags: Perspective Source Type: research
Prevalence, correlates, and quality-of-life outcomes of major or persistent pain among women living with HIV in Metro Vancouver, Canada
While women living with HIV (WLWH) are twice as likely to report severe or undertreated chronic pain compared to men, little is known about pain among WLWH. Our goal was to characterize the correlates of pain ... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 13, 2024 Category: Drugs & Pharmacology Authors: Sophia Ly, Kate Shannon, Melissa Braschel, Haoxuan Zhou, Andrea Kr üsi and Kathleen Deering Tags: Research Source Type: research
Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA
Shifts in the US drug supply, including the proliferation of synthetic opioids and emergence of xylazine, have contributed to the worsening toll of the overdose epidemic. Drug checking services offer a critica... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - January 13, 2024 Category: Drugs & Pharmacology Authors: Kyle J. Moon, Heather D. Whitehead, Anne Trinh, Kathryn A. Hasenstab, Kathleen L. Hayes, Debra Stanley, Brittany Carter, Rick Barclay, Marya Lieberman and Saira Nawaz Tags: Perspective Source Type: research
